First Patient in Agendia DEBRA Trial: Advancing Precision Breast Cancer Treatment
By Daniella Parra Agendia said it has enrolled the first patient using MammaPrint for the Oncology De-Escalation of Breast Radiation (DEBRA) Trial, aiming to reduce breast radiation post-lumpectomy for low-risk, early-stage breast cancer. The trial aims to determine whether hormonal...